A lone flower grows up from the dirt.

Like hardy desert plants, scientists persevere through challenges in the pursuit of science.

Credit: iStock/AlessandroZocc

Resiliency in science

Through research experience, scientists develop a strong sense of resiliency. The COVID-19 pandemic put that resiliency to the test, and now as vaccination rates increase and communities begin to open up, it’s time to take a breath.
Stephanie DeMarco, PhD Headshot
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

How many times did I head into the darkroom, ready with my UV protective glasses, to find that my PCR reaction had failed? I should have found clear, bright bands, but instead saw faint smears, or simply an empty gel — as if I’d never loaded my precious samples in the first place. My former lab mate used to say that running a PCR was the only time it made sense to do the same thing and hope for a different result.

While some people may think that scientists run around shouting “Eureka!” and making discoveries all day, scientists know that most of research is troubleshooting. We make one small change after another until the experiment actually works so that we can test our hypotheses.

The seemingly endless tweaking and tinkering instills a special kind of resiliency in scientists. Maybe just one more fix or one more try will finally iron out that stubborn scientific wrinkle. That perseverance gets science done.

Continue reading below...
A black mosquito is shown on pink human skin against a blurred green backdrop.
InfographicsDiscovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Read More

The COVID-19 pandemic, however, pushed scientists’ naturally-developed resiliency to the brink. Labs shut their doors to everyone but essential staff. Researchers performed wet lab work in shifts, working at all hours. Clinical trials went virtual or halted altogether. And everything from lab meetings to international conferences went online. The already measured march of scientific research slowed to a crawl in most fields.


Credit: Stephanie demarco

But like the rest of the world, scientists adapted to the new normal. They channeled their resiliency into writing review articles, learning to code and investing in bioinformatics projects, and submitting new funding applications for when the world would open once again.

Despite dealing with the stress of stay-at-home orders and a disruption in normal research conditions, scientists made spectacular discoveries during the pandemic. Besides the incredible, lightning-fast rollout of the COVID-19 vaccines, scientists developed the first vaccine for malaria, introduced a blood test for Alzheimer’s disease, and released promising data on psychedelics as treatments for depression and PTSD.

Continue reading below...
A white, pink, and blue 3D molecular structure of a simple sugar is shown against a light purple background.
WebinarsAdding a little sugar: what glycomics can bring to medicine
Discover how glycoscience is transforming how scientists understand diseases and opening new doors for drug discovery.
Read More

Now, as vaccination rates increase and communities begin to open up, it’s finally time to take a breath. Being resilient also means knowing when to stop and recharge. Just because scientists have been trained to persist and meet every challenge, doesn’t mean they can’t take a break.

As life begins to look a little bit like it did before the pandemic, take a moment or two to acknowledge all that you have accomplished during this unprecedented time. What did you learn about the process of science? What changes to the way you do research will you continue in post-pandemic times? What normal research pursuits are you excited to get back to?

And, when you’re back in the lab, frustrated because the experiment just won’t work, remember all of the obstacles you have already overcome, and run that experiment one more time.

About the Author

  • Stephanie DeMarco, PhD Headshot

    Stephanie joined Drug Discovery News as an Assistant Editor in 2021. She earned her PhD from the University of California Los Angeles in 2019 and has written for Discover Magazine, Quanta Magazine, and the Los Angeles Times. As an assistant editor at DDN, she writes about how microbes influence health to how art can change the brain. When not writing, Stephanie enjoys tap dancing and perfecting her pasta carbonara recipe.

Related Topics

Published In

september-issue-image
Volume 17 - Issue 9 | September 2021

September 2021

September 2021 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue